Regulation of estrogen receptor-α gene expression by epidermal growth factor

Journal of Endocrinology

Volumn 165, Issue 2, 2000, Pages 371-378

  Stoica, A ^a   Saceda, M ^a,b   Doraiswamy, V L ^a   Coleman, C ^a   Martin, M B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; GENE EXPRESSION REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0034078206     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650371     Document Type: Article

References (38)

1. Adachi K, Kurachi H, Homma H, Adachi H, Imai T, Sakata M, Higashiguchi O, Yamaguchi M, Morishige KI, Sakoyama Y & Miyake A 1995 Estrogen induces epidermal growth factor (EGF) receptor and its ligands in human fallopian tube: involvement of EGF but not transforming growth factor-alpha in estrogen-induced tubal cell growth in vitro. Endocrinology 136 2110-2119.
2. Bunone G, Briand PA, Miksicek RJ & Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAPK pathway and direct phosphorylation. EMBO Journal 15 2174-2183.
3. Burgering BMT & Coffer PJ 1995 Protein kinase B (c-Akt) in phosphatidyl inositol-3-OH kinase signal transduction. Nature 376 599-602.
4. Cho H, Lei ZM & Rao CV 1994 Transcriptional and posttranscriptional mechanisms in EGF regulation of human chorionic gonadotropin subunits and hCGR gene expression in human choriocarcinoma cells. Endocrinology 135 962-970.
5. Cornier EM, Wolf MF & Jordan VC 1989 Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by EGF and possible clinical implications for paracrine-regulated breast cancer growth. Cancer Research 49 576-580.
6. Curtis SW, Washhorn T, Sewall C, DiAugustine R, Lindzey Y, Couse JF & Korach KS 1996 Physiological coupling of growth factors and steroid receptor signaling pathways: ERKO mice lack estrogen-like response to EGF. Proceedings of the National Academy of Sciences of the USA 93 12626-12630.
7. Das SK, Tsukamura H, Paria BC, Andrews GK & Dey SK 1994 Different expression of EGF receptor gene and regulation of EGFR bioactivity by progesterone and estrogen in the adult mouse uterus. Endocrinology 134 971-981.
8. Earp HS, Dawson TL, Li X & Yu H 1995 Hetrodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Research and Treatment 35 115-132.
9. El-Tanani MKK & Green CD 1997a Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells. Journal Steroid Biochemistry 60 269-276.
10. El-Tanani MKK & Green CD 1997b Two separate mechanisms for ligand-independent activation of the estrogen receptor. Molecular Endocrinology 11 928-937.
11. Hafner F, Holler E & von Angerer E 1996 Effects of growth factors on estrogen receptor mediated gene expression. Journal Steroid Biochemistry 58 385-393.
12. Hana V & Murphy CJ 1994 Interdependence of EGF and IGF-I expression in the mouse uterus. Endocrinology 135 107-112.
13. Hidiaka H, Inagaki M, Kawamoto S & Sasaki Y 1984 Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23 5036-5041.
14. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA & Korach KS 1992 Coupling of dual signaling pathways: EGF action involves the ER. Procecdings of the National Academy of Sciences of the USA 89 4658-4662.
15. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS & McLachlan JA 1993 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Molecular Endocrinology 7 992-998.
16. Ignar-Trowbridge DM, Pimentel M, Teng CT, Korach KS & McLachlan JA 1995 Cross talk between peptide growth factors and estrogen receptor signaling systems. Environmental Health Perspectives 103 35-38.
17. Ignar-Trowbridge DM, Pimentel MG, Parker MG, McLachlan JA & Korach KS 1996 Peptide growth factors cross-talk with the estrogen receptor requires the A/B domain and occurs independent of protein kinase C or estradiol. Endocrinology 137 1735-1744.
18. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW & Coetzee GA 1997 Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. Journal of the National Cancer Institute 89 166-170.
19. Jensen EV 1996 Steroid hormones, receptors, and antagonists. Annals of the New York Academy of Science 784 1-16.
20. Jones PF, Jakubowitz T, Pitossi FJ, Maurer F & Hemmings BA 1995 Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Nature 376 599-602.
21. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Stao A & Kaneko M 1987 K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent kinases. Biochemical and Biophysical Research Communications 142 436-440.
22. Kastner P, Bocquel M, Turcotte B, Garnier JM, Horwitz KB, Chambon P & Gronemeyer H 1990 Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. Journal of Biological Chemistry 265 12163-12167.
23. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Nishida E, Kawashima H, Metzger D & Chambon P 1995 Activation of the estrogen receptor through phosphorylation by MAPK. Science 270 1491-1494.
24. Katzenellenbogen BS 1996 Estrogen Receptors: Bioactivity and Interactions with Cell Signaling Pathways. Biology of Reproduction 54 287-293.
25. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME & McInery EM 1997 Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Research and Treatment 44 23-38.
26. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesano K, Blumherg B, Kastner P, Mark M, Chambon P & Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839.
27. Masiakowski P, Breathnach R, Bloch J, Cannon F, Krust A & Chambon P 1982 Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Research 10 7895-7903.
28. Norderu SK, Moyer ML & Bona BJ 1994 The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology 34 1723-1732.
29. O'Malley BW, Schrader T, Mani S, Smith C, Weigel N, Conneely OZM & Clark JH 1994 An alternate ligand-independent pathway for activation of steroid receptors. Recent Progress in Hormone Research 50 333-347.
30. Picard P. Bunone G. Liu JW & Donze O 1997 Steroid-independent activation of steroid receptors in mammalian and yeast cells in breast cancer. Biochemical Society Transactions 25 597-602.
31. Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A & Osborne CK 1992 Inhibition of breast cancer cells growth in vitro by a tyrosine kinase inhibitor. Cancer Research 52 3636-3641.
32. Saceda M, Lippman ME, Chambon P, Lindsey RK, Ponglikitmongkol M. Puente M & Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Molecular Endocrinology 2 1157-1162.
33. Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R & Martin MB 1996 Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines. Endocrinology 137 4322-4330.
34. Stancel GM, Gardner RM, Kirland JL, Liu TH, Lingham RB, Loose-Mitchell DS, Mukku VR, Orengo CA & Verner G, 1987 Interactions between estrogen and EGF in uterine growth. Advances in Experimental Medical Biology 230 99-118.
35. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD & Martin MB 1997 The role of transforming growth factor-B in regulation of estrogen receptor expression in the MCF-7 breast cancer cell line. Endocrinology 138 1498-1505.
36. Sumida C & Pasqualim JR 1989 Antiestrogens antagonize the stimulatory effect of EGF on the induction of progesterone receptor in fetal uterine cells in culture. Endocrinology 124 1242-1259.
37. Tsai MJ & O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry 63 451-486.
38. Vlahos CJ, Matter WF, Kui KY & Brown RF 1994 A specific inhibitor of phosphatidylmositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry 269 5241-5248.